2 completed. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
Follow ABX464 50mg: new trials by email Literature Review of ABX464 50mg trials Research Report on ABX464 50mg
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Two Doses of ABX464 in Participants With Moderate to Severe Rheumatoid Arthritis ABX464 50mg, Matching Placebo, ABX464 100mg - Rheumatoid Arthritis | Phase 2 | Completed | Abivax S.A. | 60 | 2019-07-04 | 2023-02-15 |
| A Safety, Pharmacokinetics, and Pharmacodynamics Study of ABX464 in HIV-1 Seronegative and Seropositive Adults ABX464 150mg, ABX464 50mg - HIV Infections, Health Volunteers | Phase 1 / Phase 2 | Completed | Abivax S.A. | 36 | 2017-03-27 | 2023-03-31 |
Arthritis, Rheumatoid (1) · HIV Infections (1)
Abivax S.A. (2)
Belgium (1) · Czechia (1) · France (1) · Hungary (1) · Poland (1) · Spain (1)